Navigation Links
Rise in Vulvar Precancers Leads to New Guidelines
Date:10/20/2011

THURSDAY, Oct. 20 (HealthDay News) -- The number of American women with precancerous cells of the vulva increased more than fourfold between 1973 and 2000, and the increase has led to the release Thursday of new treatment guidelines by two major medical groups.

Cancer of the vulva -- the outside of the genital area -- is usually caused by infection with human papillomavirus (HPV), which also causes cervical cancer. The precancerous condition -- known as vulvar intraepithelial neoplasia (VIN) -- should be treated with surgery, laser removal or medical therapy, according to the new guidelines from the American College of Obstetricians and Gynecologists and the American Society for Colposcopy and Cervical Pathology.

VIN is divided into two main types. Usual-type VIN is often associated with cancer-causing strains of HPV and risk factors such as smoking and a weakened immune system. Differentiated VIN is often linked to dermatologic conditions of the vulva.

In most cases of VIN, which is increasingly evident among women in their 40s, there are visible raised lesions that may be white, gray, red, brown or black.

"Most women with VIN will not notice any symptoms, but some may have bleeding, discharge, or itching," Dr. Gerald F. Joseph, Jr., ACOG's vice president for practice activities, said in a college news release.

"It would be sensible for women to periodically examine their vulvar area for any unusual spots or lesions, and if they find something, make an appointment with their ob-gyn," he advised.

While VIN appears to be increasing in the United States, the risk of vulvar cancer is small when compared with cervical, ovarian and uterine cancers, Dr. L. Stewart Massad, a member of ACOG's Committee on Gynecologic Practice, said in the news release.

Much like precancerous cervical lesions, VIN is generally slow-growing, he said. "The quadrivalent HPV vaccine that helps prevent cervical cancer and genital warts has also been shown to decrease the risk of VIN," Massad noted.

Visual examination is the only way to diagnose VIN, and most lesions will need to be biopsied. If cancer is suspected, surgery is the preferred treatment. Laser removal is an acceptable treatment for VIN lesions that appear precancerous. Low-grade lesions can be monitored or treated with a topical cream (5 percent imiquimod) for 12 to 20 weeks, according to the guidelines.

The recurrence rate of VIN is high regardless of the treatment method, and women who've had VIN remain at risk for recurrent VIN and vulvar cancer for the remainder of their lives.

-- Robert Preidt

SOURCE: American College of Obstetricians and Gynecologists, news release, Oct. 20, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Chronic vulvar pain a reality for more than 100,000 women in southeast Michigan
2. Learning Lab of Brentwood Leads Free ADHD Seminar
3. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
4. TechCFO Enters Mid-Atlantic Market; Rick Rolandi Leads DC Metro Office
5. Home Health Agency Owner Pleads Guilty in Connection with Detroit Fraud Scheme
6. New DNA technique leads to a breakthrough in child cancer research
7. AGA leads the way in GI innovation
8. Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk
9. KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs
10. China's Forbidden City Leads Landmark Climate Action for Earth Hour
11. McMaster researcher leads development of promising drug for inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rise in Vulvar Precancers Leads to New Guidelines  
(Date:4/30/2016)... ... April 30, 2016 , ... Dr. Trevor Gardner, ... EMED, today signed a multifaceted agreement which will allow for the research and ... Department of Natural and Applied Sciences, Allied Health and Nursing will work together ...
(Date:4/30/2016)... ... ... is a challenge for all of us, but there are things we can do to improve ... “Research is showing more and more that there are simple, yet important steps that can be ... Top priorities Dr. Kohli’s recommends for her patients include;, , exercise ...
(Date:4/29/2016)... , ... April 30, 2016 , ... ... of patented products, announces the Pick Up Springboard, an automotive invention that improves ... Truck Manufacturing industry is worth $162 billion," says Scott Cooper, CEO and Creative ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article ... divorcee, shares her enthusiasm for Botox and lip injections, which she underwent in order ... oriented Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation ...
(Date:4/29/2016)... ... 29, 2016 , ... Memorial Healthcare System Graduate Medical ... (ACGME) that it has received accreditation for its residency program on Physical Medicine ... that Memorial is currently pursuing, including Pediatrics and Internal Medicine. This accreditation allows ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Mich. , April 28, 2016   ... . Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... has signed a definitive agreement to acquire Valley ... Specialty Pharmacy ("TNH"), a leading specialty pharmacy that ... Van Nuys, California . In 2015, TNH ...
(Date:4/28/2016)... TOKYO , April 28, 2016 /PRNewswire/ ... Ahuja , George Phillips und ... wachsenden Unternehmens    ArisGlobal®, ein ... Life Sciences, gab heute bekannt, dass neue ... wachsenden Unternehmens gestoßen sind, die vielfältige Erfahrungen ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
Breaking Medicine Technology: